Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
BNR: Burning Rock Biotech Limited Stock Analysis | finqOS
Healthcare · Medical - Diagnostics & Research
The Story
BNR
The Story
BNR
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+4.6% / yr
Operating margin
-11.4%
ROIC
-10.1%
Financially safe
Stretched
Debt / equity
0.10×
Interest coverage
-1300.2×
Current ratio
3.05×
Burning Rock Biotech Limited
BNR
NASDAQ Global Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Burning Rock Biotech Limited
BNR
NASDAQ
·
USD
·
Closed
$8.90
+0.56%
$8.90
+$0.05 (0.56%)
52W Range
10th
pctl
Volume
0.07×
avg
Mkt Cap
9.41M
USD
P/E
-1.1
TTM
Div Yield
–
ann
52W Range
10th
pctl
Volume
0.07×
avg
Market Cap
9.41M
USD
P/E Ratio
-1.1
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings